|Videos|August 5, 2017

Once Labeled, Always Labeled: Addressing Misconceptions About Penicillin Allergies

Elizabeth Phillips, MD, FRCPC, FRACP, addresses the misconceptions about penicillin allergies.

Elizabeth Phillips, MD, FRCPC, FRACP, Professor of Medicine, Pharmacology, and Pathology, Vanderbilt University Medical Center, addresses the misconceptions about penicillin allergies.

Interview Transcript (slightly modified for readability)

“I think that there’s a lot of misperceptions about antibiotic allergy, and penicillin in particular. There’s this overriding superstition that once [someone’s] labeled, [they’re] always labeled, and I think the educational aspect of it is huge.

I think education around the fact that most patients, in fact, 99% of patients that are labeled, are unlikely to have true penicillin allergy. Penicillin allergy is something that does tend to wane over time; and so, even if a patient mechanistically has had a defined true allergy—a serious, life-threatening allergy—at some point in their life, they tend to lose the tendency to that over time to the point that after about 10 years, there’s a very good chance they would be no longer allergic.

I think the take-home message is it’s always worth considering—regardless of the severity of the reaction or the history—the ‘work-up’ of somebody that has actually been labeled with penicillin allergy.”


Related to this article

Ceftriaxone Safety: Separating Signal From Risk
A retrospective multihospital study found that severe adverse events occurred at similarly low rates with ceftriaxone and other IV cephalosporins suggesting there is no evidence to support avoiding ceftriaxone despite recent health department safety alerts.
Treatment of Latent Tuberculosis in a Trice
A retrospective study of 225 patients across Cook County Department of Health clinics found that the novel 1-month 1HP regimen (isoniazid plus rifapentine) for latent TB infection had a completion rate comparable to standard longer regimens and was well tolerated, suggesting it may be a viable shorter alternative.
Peggy Lillis Foundation Will Honor C diff Advocates at Annual Gala
The Peggy Lillis Foundation will host its 17th Annual Changing the Odds Gala this month in New York City, and it will include a casino, fellowship amongst the C diff community, and an award ceremony honoring a physician-scientist, philanthropist, a researcher, and a patient advocate for their contributions to C difficile awareness, treatment, and prevention.